Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.4.4 (
adenosine deaminase
)
5,136
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A model is proposed for the partial depletion of the adenine nucleotide pool in the ischemic perfused rat heart which involves seven enzymes: adenylate cyclase, 3',5'-cyclic AMP phosphodiesterase, 5'-nucleotidase, adenosine kinase,
adenosine deaminase
, purine nucleoside phosphorylase, and inorganic pyrophosphatase. The computer implementation of this model is in terms of rate laws, several of which were obtained by a systematic least-squares fitting procedure. Depletion of the adenine nucleotide pool is initiated by the release of endogenous noradrenaline into the interstitial fluid, which results from a fall in tissue PO2, and the subsequent activation of adenylate cyclase. In this model the substrate for 5'-nucleotidase is a
membrane-bound
AMP pool formed by hydrolysis of extracellular fluid and functions as a vasodilator; excess adenosine is incorporated into the tissue by a "permease" with Michaelis-Menten kinetics and converted to AMP, inosine, and hypoxanthine. Alternative mechanisms, such as the deamination of AMP by adenylate deaminase and conversion of AMP to adenine by AMP pyrophosphorylase, were rejected primarily on qualitative biochemical grounds.
...
PMID:Computer simulation of ischemic rat heart purine metabolism. I. Model construction. 19 89
In Micrococcus sodonensis and some other Micrococcus species, adenosien deaminase is present both as a membran-bound and a soluble enzyme; The membran-bound
adenosine deaminase
can be extracted with n-butanol, and may account for up to 5% of the total cellular
adenosine deaminase
activity. In a number oc comparative tests, no differences between the two enzyme forms could be found, thus they are believed to be similar molecular species; The purified membran-bound or soluble enzyme had a molecular weight, obtained by gel-filtration, of 130 000 and was inactive toward adenine and adenine mononucleotides. It appears, therefore, to be more closely related to the calf-intestine enzyme than the Aspergillus oryzae form in respect to size and substrate specificity; Attempts to correlate
membrane-bound
adenosine deaminase
activity with adenosine transport in isolated membrane vesicles of M. sodonensis indicated no obvious relationship between the two activities.
...
PMID:Purification and some properties of the soluble and membrane-bound adenosine deaminases of Micrococcus sodonensis ATCC 11880 and their distribution within the family Micrococcacea. 116 29
Chlorotetracycline has been used in human polymorphonuclear leukocytes as a probe to investigate the state of
membrane-bound
calcium. We examined the effect of adenosine on the fluorescence responses of CTC-loaded PMNs stimulated with the synthetic chemotactic peptide, formyl-methionyl-leucyl- phenylalanine. Adenosine inhibited the decrease in CTC fluorescence in a dose-dependent fashion and its effect was reversed by theophylline, an adenosine receptor antagonist. Removal of extracellular adenosine by incubating PMNs with
adenosine deaminase
abolished the effect of adenosine. These data suggest that adenosine inhibits the release of
membrane-bound
calcium in PMNs that normally occurs in response to chemotactic stimuli, acting via PMN surface adenosine receptors.
...
PMID:The effect of adenosine on the fluorescence responses of chlorotetracycline-loaded human polymorphonuclear leukocytes. 238 62
The changes in the biochemical parameters of peritoneal macrophages and their coupling to the secretory and phagocytic functions in CH3A mice during the growth of the reinoculated solid hepatoma 22a were studied. The DNA and RNA synthesis during the active tumour growth was more intense than that in resident macrophages. The activity of uridine kinase increased up to 156.0 +/- 12.0 nmol/hour/10(8) but was absent in resident macrophages. This was accompanied by a 7.2-fold increase of interleukin-1 synthesis as determined by the [3H]thymidine incorporation into thymocyte DNA in response to concanavalin A administration to C3H mice. Similar changes were observed in peptone-stimulated macrophages. A specific feature of macrophages from tumour-bearing mice was the impairment of activity of purine exchange enzymes and the efficiency of phagocytosis that were unobserved in peptone-stimulated macrophages. The activity of
adenosine deaminase
and purine nucleoside phosphorylase was inhibited as a result of their preincubation with zymosan, a phagocytosis-stimulating agent. This was accompanied by a significant decrease of the first chemiluminescence peak resulting from disturbances in Fc-reception. Macrophages of tumour-bearing animals possessed an increased 2.2-fold activity of
membrane-bound
AMP 5'-nucleotidase concomitant with the lack or decrease of the amplitude of the second chemiluminescence peak reflecting the disturbances in digestion resulting from phagocytosis.
...
PMID:[Change in activity of enzymes for purine metabolism and RNA and DNA biosynthesis in macrophages, reflecting impairment of their functions in neoplastic growth]. 248 7
1. Rats (4 weeks old) were made hypothyroid by treatment with propylthiouracil and a low-iodine diet for a further period of 4 weeks. Synaptosomal membranes, myelin and 105,000 g soluble fractions were obtained from six regions of the brain. 2. Hypothyroidism resulted in 2-5-fold increases in
membrane-bound
5'-nucleotidase activity in synaptosomal fractions obtained from cerebellum, cortex, striatum and hippocampus. By contrast, myelin 5'-nucleotidase activity was slightly increased only in the medulla oblongata. 3. Hypothyroidism did not change
adenosine deaminase
activity, but decreased adenosine kinase activity by approx. 40% in soluble fractions obtained from cerebellum, hippocampus, striatum and hypothalamus. 4. It is suggested that these changes in hypothyroidism, in particular the increases in 5'-nucleotidase activity, could enhance the neuromodulatory effect of adenosine to decrease neurotransmitter release.
...
PMID:Changes in the activities of adenosine-metabolizing enzymes in six regions of the rat brain on chemical induction of hypothyroidism. 254 78
The activities of the adenosine-generating enzyme 5'-nucleotidase and the adenosine-degrading enzyme
adenosine deaminase
were determined for four regions of rat hearts prior to and following 10-60 min of ischaemia. Whereas
adenosine deaminase
was uniformly active throughout the heart, 5'-nucleotidase was twice as active in atrial than in ventricular myocardium, and more active in the right than in the left ventricles in normoxic tissues. In isolated heart preparations normoxic perfusion decreased
adenosine deaminase
and increased 5'-nucleotidase activity compared to levels in vivo. Global ischaemia for 10 min elevated
adenosine deaminase
activity but had no effect on 5'-nucleotidase activity. However, 30 min of ischaemia decreased 5'-nucleotidase activity by 50% in all regions of the heart. These changed levels were not altered by 10 min of reperfusion. The fall in 5'-nucleotidase activity with ischaemia occurred only in the 90% of this enzyme which is
membrane-bound
. The reasons for the marked differences in distribution and responses to ischaemia of these two enzymes have yet to be elucidated but metabolic inhibitors seem unlikely to be involved.
...
PMID:Differences in the regional distribution and response to ischaemia of adenosine-regulating enzymes in the heart. 282 14
Incubation of slices of rat cerebral cortical grey matter in Krebs-Ringer bicarbonate-glucose buffer induced a rapid decline in the responsiveness of the adenylate cyclase in subsequently prepared membrane preparations to stimulation by various activators of the enzyme. The loss of responsiveness was time- and temperature-dependent, showed an absolute dependence on extracellular calcium ions, and was mimicked by the presence of serine proteases in the incubation medium. The resultant adenylate cyclase preparation was partially responsive to activation by fluoride and guanylylimidodiphosphate but had become virtually unresponsive to activation by ganglioside, trypsin, or beta-adrenergic agonists. The loss of responsiveness of adenylate cyclase was not altered if slices were incubated with depolarizing agents, putative neurotransmitters, receptor blockers, serine protease inhibitors, or
adenosine deaminase
. The nature of the calcium-dependent mechanism involved in the loss responsiveness of membranal adenylate cyclase is unknown. A suggested mechanism for the loss of sensitivity is the action of a
membrane-bound
, calcium-dependent protease.
...
PMID:Calcium-dependent desensitization of adenylate cyclase in rat cerebral cortical slices. 625 74
Adenosine is known to modulate adenylate cyclase activity in a variety of tissues. We have tested the effects of adenosine on basal activity and the catecholamine- or prostaglandin E1-stimulated activity of the human fat cell adenylate cyclase. Adenosine caused a dose-dependent inhibition of basal enzyme activity as well as of adrenaline-and prostaglandin E1-stimulated rates of 3',5'-cyclic AMP accumulation. The adenosine-induced inhibition was specific since other nucleosides or their respective nitrogenous parent bases, with the exception of adenine, failed to mimic the action of adenosine. In addition, the adenosine-induced inhibition could be reversed by inclusion of
adenosine deaminase
. The results are compatible with the concept of adenosine acting as an inhibitor of lipolysis at the level of the
membrane-bound
adenylate cyclase. They show that this nucleoside can also inhibit the prostaglandin E1-induced stimulation of the human fat cell adenylate cyclase thereby suggesting that the effects of adenosine and prostaglandins might be antagonistic under conditions where prostaglandins act as stimulators of lipolysis.
...
PMID:Inhibition of the stimulatory effect of adrenaline and prostaglandin E1 on the human fat cell adenylate cyclase by adenosine. 739 Mar 97
A high-affinity binding site for 5'-N-ethylcarboxamido[3H]adenosine ([3H]NECA) from bovine cerebral cortex has been characterized in its
membrane-bound
and solubilized state after gel filtration on Sepharose CL-6B. For detection of this site in membranes, it was necessary to remove metabolites with high affinities for this site enzymatically, e.g., adenosine by addition of
adenosine deaminase
and inosine by addition of nucleoside phosphorylase. The pore-forming peptide antibiotic alamethicin further enhanced binding of [3H]NECA to this site in membranes. In contrast to adenosine receptors and the adenotin-like low-affinity binding protein, this novel site was extremely sensitive against treatment with the sulfhydryl alkylating agent N-ethylmaleimide. In competition experiments, this site could be differentiated from adenosine receptors by its high affinity for adenine nucleotides and its lack of affinity for adenosine receptor antagonists. Inosine and its derivative S-(4-nitrobenzyl)-6-thioinosine were relatively potent ligands with Ki values in the high nano- and low micromolar range, respectively. We conclude that the high-affinity NECA binding site described previously in bovine striatum is not exclusively located in the striatum, but can also be detected in membrane preparations and soluble extracts of bovine brain cortex.
...
PMID:Characterization of membrane-bound and solubilized high-affinity binding sites for 5'-N-ethylcarboxamido[3H]adenosine from bovine cerebral cortex. 841 49
Dipeptidyl peptidase IV (DPP IV) in normal human serum was purified 14,400-fold with a 25% yield to homogeneity. The molecular weight of the purified enzyme was approximately 110,000 on SDS-PAGE, almost the same as that of human kidney
membrane-bound
DPP IV. No difference was found between the two enzymes enzymologically and immunologically, either in substrate specificity, susceptibility to inhibitors, or cross-reactivity with an anti-rat kidney DPP IV antibody, or in their ability to bind
adenosine deaminase
. However, the N-terminal amino acid sequence of serum DPP IV lacked the transmembrane domain of the
membrane-bound
enzyme and started at the 39th position, serine, from the N-terminus predicted from the cDNA nucleotide sequence. These results suggest that
membrane-bound
DPP IV loses its transmembrane domain upon release into the serum, and that its structure on the plasma membrane is not required for its binding to
adenosine deaminase
.
...
PMID:Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. 968 37
1
2
3
Next >>